138 related articles for article (PubMed ID: 25081684)
1. Four polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene and lung cancer risk: a meta-analysis.
Bu ZB; Ye M; Cheng Y; Wu WZ
Asian Pac J Cancer Prev; 2014; 15(14):5673-9. PubMed ID: 25081684
[TBL] [Abstract][Full Text] [Related]
2. Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.
Zhenzhen L; Xianghua L; Ning S; Zhan G; Chuanchuan R; Jie L
Eur J Cancer Prev; 2013 Nov; 22(6):607-19. PubMed ID: 23462460
[TBL] [Abstract][Full Text] [Related]
3. CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.
Ma Z; Guo W; Gong T; Niu HJ; Wang RW; Jiang YG
Tumour Biol; 2014 Mar; 35(3):2253-7. PubMed ID: 24293373
[TBL] [Abstract][Full Text] [Related]
4. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
Sun WX; Chen YH; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Shen XL; He XF; Wu LX; Wei W; Zhang L
Mol Genet Genomics; 2015 Apr; 290(2):709-25. PubMed ID: 25472037
[TBL] [Abstract][Full Text] [Related]
5. quantitative assessment of the influence of cytochrome P450 1A2 gene polymorphism and colorectal cancer risk.
Zhao Y; Chen ZX; Rewuti A; Ma YS; Wang XF; Xia Q; Fu D; Han YS
PLoS One; 2013; 8(8):e71481. PubMed ID: 23951174
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.
Wang H; Zhang Z; Han S; Lu Y; Feng F; Yuan J
BMC Cancer; 2012 Nov; 12():528. PubMed ID: 23157985
[TBL] [Abstract][Full Text] [Related]
7. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
Zeng Y; Jiang HY; Wei L; Xu WD; Wang YJ; Wang YD; Liu C
Asian Pac J Cancer Prev; 2015; 16(16):7249-54. PubMed ID: 26514519
[TBL] [Abstract][Full Text] [Related]
8. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Song L; Du Q; Jiang X; Wang L
J Clin Pharm Ther; 2014 Apr; 39(2):204-9. PubMed ID: 24372004
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.
Vukovic V; Ianuale C; Leoncini E; Pastorino R; Gualano MR; Amore R; Boccia S
BMC Cancer; 2016 Feb; 16():83. PubMed ID: 26865042
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of correlation between the CYP1A2 -3860 G > A polymorphism and lung cancer risk.
Ren J; He BZ; Zhang TS; Lu SP; Yan T
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323197
[TBL] [Abstract][Full Text] [Related]
12. Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population.
Matakova T; Halasova E; Dzian A; Hruby R; Halasa M; Javorka K; Skerenova M
Adv Exp Med Biol; 2016; 911():23-32. PubMed ID: 26987327
[TBL] [Abstract][Full Text] [Related]
13. Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies.
Tian Z; Li YL; Zhao L; Zhang CL
Gene; 2013 Jul; 524(2):168-74. PubMed ID: 23628800
[TBL] [Abstract][Full Text] [Related]
14. CYP1A2 rs2069514 polymorphism and lung cancer susceptibility: a meta-analysis.
Shao W; He J
Ann Transl Med; 2015 May; 3(7):93. PubMed ID: 26015935
[TBL] [Abstract][Full Text] [Related]
15. CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis.
Siokas V; Karampinis E; Aloizou AM; Mentis AA; Liakos P; Papadimitriou D; Liampas I; Nasios G; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurol Sci; 2021 Jan; 42(1):175-182. PubMed ID: 32592103
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
17. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
[TBL] [Abstract][Full Text] [Related]
18. Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.
Kim IY; O'Reilly ÉJ; Hughes KC; Gao X; Schwarzschild MA; McCullough ML; Hannan MT; Betensky RA; Ascherio A
Mov Disord; 2018 Mar; 33(3):414-420. PubMed ID: 29318639
[TBL] [Abstract][Full Text] [Related]
19. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study.
Pavanello S; Fedeli U; Mastrangelo G; Rota F; Overvad K; Raaschou-Nielsen O; Tjønneland A; Vogel U
Cancer Genet; 2012 Jun; 205(6):278-84. PubMed ID: 22749033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
